Group 1 - The core point of the article is that Weipage (SH 603956) announced a board meeting to discuss the proposal for the absorption and merger of its wholly-owned subsidiary [1] - Weipage's revenue composition for the year 2024 is as follows: 73.5% from water resource specialized equipment manufacturing, 17.21% from water and irrigation industry software and solutions, 9.09% from other businesses, and 0.19% from miscellaneous [1] - As of the report, Weipage's market capitalization is 3.7 billion yuan [1] Group 2 - The article also highlights that Chinese innovative drugs have generated $80 billion in overseas licensing this year, indicating a hot secondary market in biomedicine, while the primary market is facing fundraising challenges [1]
威派格:10月24日召开董事会会议